Supplement Structure Function Claims

Definition

Structure/function claims are the label and marketing phrases that imply bodily support without claiming to diagnose, prevent, cure, treat, or mitigate disease - the narrow band of meaning that supplement regulation allows across the wiki’s sources.

Current Synthesis

Why is there a supplement craze if they don’t even work? establishes the U.S. version of the boundary. Frank Cantone gives “supports metabolism” as acceptable phrasing, Melanie Benish says words such as “supports” and “promotes” should signal to consumers that the benefit is not proven the way a drug claim would be, and the FDA disclaimer on the label does not stop shoppers from treating the wording as authoritative. The concept is practical rather than academic: claim vocabulary can carry much of the product’s value while remaining inside Dietary Supplement Regulation and the Dietary Supplement Health and Education Act.

The Australian counterpart comes from Vol.275 澳洲保健品是怎么火起来的？, which shows that the listed AUSTL track permits only low-risk ingredients and low-level permitted claim wording - so claim scope is bounded in a way that makes the regime look stricter than the U.S. route - and that the categories competing for purchase are not argued on claim evidence at all. Swisse’s gender-segmented multivitamins, natural-sounding ingredients, and lifestyle advertising sell a feeling of targeted effectiveness, and the hosts note that Australian officials periodically extend the permitted function descriptions, which then generate demand - the addition of a bone-and-joint-health claim is their example for a glucosamine boom. The synthesis is that permitted claim language sets the ceiling on what a product may say, while the competitive work happens in positioning, segmentation, and marketing.

Key Claims

• Claim wording carries much of the product’s value even when evidence for healthy consumers is weak.
• “Supports” and “promotes” language suggests benefit without becoming a disease-treatment claim.
• Label disclaimers may not change how consumers read health-oriented packaging.
• The Australian listed track bounds both ingredients and claim vocabulary, constraining language more visibly without adding proof of benefit.
• Adding a new permitted function description can create a new product category, which shows the claim list acting as demand infrastructure.
• Marketing can bypass the claim boundary by selling targeting, naturalness, and lifestyle rather than asserted benefit.

Evidence

• U.S. claim vocabulary: Why is there a supplement craze if they don’t even work? records Frank Cantone’s “supports metabolism” example and Melanie Benish’s reading that supports-and-promotes phrasing signals an unproven claim.
• Disclaimer limits: Why is there a supplement craze if they don’t even work? says the FDA disclaimer does not necessarily prevent consumers from treating claims as authoritative.
• Enforcement gap: Why is there a supplement craze if they don’t even work? follows Prevagen’s claims into a FTC action that took years to resolve.
• Australian claim boundary: Vol.275 澳洲保健品是怎么火起来的？ says the listed AUSTL track allows only permitted low-risk ingredients and low-level permitted claim expression.
• Permission as demand: Vol.275 澳洲保健品是怎么火起来的？ describes a newly added bone-and-joint-health function description generating a wave of glucosamine products.
• Marketing beside claims: Vol.275 澳洲保健品是怎么火起来的？ shows gendered multivitamins, natural ingredients, and lifestyle advertising carrying the sale while claim vocabulary stays minimal.

Counterevidence & Qualifications

Claim rulebooks differ by jurisdiction and change over time, so this page records patterns rather than a compliance guide; permitted wording, disclaimer requirements, and enforcement posture must be checked against current regulator guidance. The Australian material is one podcast’s summary, and the glucosamine example is a demand observation rather than an efficacy finding, while the U.S. material rests on reporting about one statute and a small set of cases. Nothing here establishes that permitted claims are meaningless - bounded vocabulary still excludes disease-treatment promises - only that the wording should be read as a legal ceiling rather than as evidence.

What Changed

• Migrated the page to synthesis-v1.
• Added the Australian listed-track claim boundary and the observation that new permitted function descriptions can create new demand.
• Recorded that lifestyle and segmentation marketing can carry a sale that claim vocabulary alone could not.

Related Concepts

• Dietary Supplement Regulation - U.S. framework that creates the claim band.
• Dietary Supplement Health and Education Act - statute behind the language rules.
• Australian Therapeutic Goods Regulation / 澳洲保健品监管 - listed-versus-registered regime with its own permitted-claim vocabulary.
• Functional Food Regulatory Identity / 功能食品监管身份 - product-identity question that precedes claim interpretation.
• Supplement Placebo Effect - consumer experience that claim language can amplify.
• Supplement Marketing Intensity / 保健品营销强度 - marketing layer that works beside the claim boundary.
• Gendered Supplement Segmentation / 性别细分保健品 - positioning device used when claim wording cannot do the work.
• Medical AI Marketing Risk - adjacent health-marketing authority risk.